AVI BioPharma - News Release

AVI BioPharma - News Release: "AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced that it has initiated dosing in a Phase 2 study of eteplirsen, the Company's lead exon-skipping therapeutic candidate for the treatment of Duchenne muscular dystrophy (DMD)"

Heart Failure Drugs Preserve Muscle in Muscular Dystrophy

Heart Failure Drugs Preserve Muscle in Muscular Dystrophy: "COLUMBUS, Ohio – Two common drugs used to treat heart failure might also improve heart and muscle function in Duchenne muscular dystrophy (DMD), according to a new study. "

Researchers discover biological mechanism behind sarcopenia

Researchers discover biological mechanism behind sarcopenia: "Researchers at Columbia University Medical Center have discovered the biological mechanism behind age-related loss of muscle strength and identified a drug that may help reverse this process."